3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Neoplasm Metastasis
11
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Neoplasms
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Glioblastoma
2
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Hormone Receptor Positive Breast Cancer
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Interventions
Doxorubicin
6
pazopanib
5
Gemcitabine
4
pembrolizumab
3
Trabectedin
3
Sorafenib
3
Docetaxel
3
Dacarbazine
3
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
Nivolumab
2
Letrozole
2
Ifosfamide
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
saracatinib
1
sapanisertib
1
rucaparib
1
romidepsin
1
olaratumab
1
mocetinostat
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
durvalumab
1
cixutumumab
1
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leiomyosarcoma
×
abemaciclib
×
Clear all
No trials found.